Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 27.43 Billion USD | 7.89% |
| 2022 | 25.42 Billion USD | -13.03% |
| 2021 | 29.23 Billion USD | -4.44% |
| 2020 | 30.59 Billion USD | -6.52% |
| 2019 | 32.72 Billion USD | 32.86% |
| 2018 | 24.63 Billion USD | -21.93% |
| 2017 | 31.55 Billion USD | -21.65% |
| 2016 | 40.27 Billion USD | -6.2% |
| 2015 | 42.93 Billion USD | 105.25% |
| 2014 | 20.91 Billion USD | -8.0% |
| 2013 | 22.73 Billion USD | 59.75% |
| 2012 | 14.23 Billion USD | 55.81% |
| 2011 | 9.13 Billion USD | 55.25% |
| 2010 | 5.88 Billion USD | 725.63% |
| 2009 | 712.67 Million USD | 68.89% |
| 2008 | 421.96 Million USD | -12.87% |
| 2007 | 484.29 Million USD | -45.59% |
| 2006 | 890.14 Million USD | 10.09% |
| 2005 | 808.54 Million USD | 23.66% |
| 2004 | 653.86 Million USD | -37.2% |
| 2003 | 1.04 Billion USD | 5.37% |
| 2002 | 988.11 Million USD | 381.05% |
| 2001 | 205.4 Million USD | -76.38% |
| 2000 | 869.8 Million USD | 335.34% |
| 1999 | 199.8 Million USD | 34.36% |
| 1998 | 148.7 Million USD | 717.03% |
| 1997 | 18.2 Million USD | -16.13% |
| 1996 | 21.7 Million USD | -53.13% |
| 1995 | 46.3 Million USD | 158.66% |
| 1994 | 17.9 Million USD | -30.89% |
| 1993 | 25.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 26.78 Billion USD | 0.24% |
| 2024 Q2 | 26.71 Billion USD | -1.26% |
| 2024 Q1 | 27.05 Billion USD | -1.36% |
| 2023 Q3 | 27.29 Billion USD | -18.36% |
| 2023 FY | 27.43 Billion USD | 7.89% |
| 2023 Q4 | 27.43 Billion USD | 0.49% |
| 2023 Q2 | 33.43 Billion USD | 32.16% |
| 2023 Q1 | 25.3 Billion USD | -0.5% |
| 2022 Q4 | 25.42 Billion USD | -1.7% |
| 2022 FY | 25.42 Billion USD | -13.03% |
| 2022 Q1 | 29.23 Billion USD | -0.02% |
| 2022 Q2 | 27.91 Billion USD | -4.49% |
| 2022 Q3 | 25.86 Billion USD | -7.35% |
| 2021 Q3 | 29.38 Billion USD | -4.13% |
| 2021 Q1 | 30.32 Billion USD | -0.89% |
| 2021 Q4 | 29.23 Billion USD | -0.51% |
| 2021 Q2 | 30.65 Billion USD | 1.09% |
| 2021 FY | 29.23 Billion USD | -4.44% |
| 2020 Q4 | 30.59 Billion USD | -1.01% |
| 2020 Q3 | 30.9 Billion USD | 0.18% |
| 2020 FY | 30.59 Billion USD | -6.52% |
| 2020 Q1 | 31.07 Billion USD | -5.05% |
| 2020 Q2 | 30.85 Billion USD | -0.72% |
| 2019 Q1 | 29.77 Billion USD | 20.87% |
| 2019 FY | 32.72 Billion USD | 32.86% |
| 2019 Q4 | 32.72 Billion USD | 12.44% |
| 2019 Q3 | 29.1 Billion USD | -1.88% |
| 2019 Q2 | 29.66 Billion USD | -0.36% |
| 2018 Q4 | 24.63 Billion USD | -19.35% |
| 2018 FY | 24.63 Billion USD | -21.93% |
| 2018 Q3 | 30.54 Billion USD | -1.13% |
| 2018 Q2 | 30.89 Billion USD | -1.23% |
| 2018 Q1 | 31.27 Billion USD | -0.88% |
| 2017 Q4 | 31.55 Billion USD | -8.68% |
| 2017 Q3 | 34.55 Billion USD | -8.36% |
| 2017 Q1 | 38.33 Billion USD | -4.8% |
| 2017 FY | 31.55 Billion USD | -21.65% |
| 2017 Q2 | 37.7 Billion USD | -1.66% |
| 2016 Q2 | 42.25 Billion USD | -2.28% |
| 2016 Q1 | 43.24 Billion USD | 0.72% |
| 2016 FY | 40.27 Billion USD | -6.2% |
| 2016 Q3 | 41.48 Billion USD | -1.83% |
| 2016 Q4 | 40.27 Billion USD | -2.93% |
| 2015 Q4 | 42.93 Billion USD | 2.25% |
| 2015 Q2 | 41.78 Billion USD | 30.62% |
| 2015 FY | 42.93 Billion USD | 105.25% |
| 2015 Q1 | 31.99 Billion USD | 52.93% |
| 2015 Q3 | 41.98 Billion USD | 0.49% |
| 2014 FY | 20.91 Billion USD | -8.0% |
| 2014 Q2 | 22.52 Billion USD | -1.13% |
| 2014 Q3 | 21.82 Billion USD | -3.12% |
| 2014 Q4 | 20.91 Billion USD | -4.16% |
| 2014 Q1 | 22.78 Billion USD | 0.21% |
| 2013 Q3 | 23.14 Billion USD | 64.37% |
| 2013 Q4 | 22.73 Billion USD | -1.75% |
| 2013 Q2 | 14.07 Billion USD | 1.3% |
| 2013 Q1 | 13.89 Billion USD | -2.34% |
| 2013 FY | 22.73 Billion USD | 59.75% |
| 2012 FY | 14.23 Billion USD | 55.81% |
| 2012 Q1 | 9.54 Billion USD | 4.47% |
| 2012 Q2 | 10.32 Billion USD | 8.18% |
| 2012 Q3 | 10.36 Billion USD | 0.35% |
| 2012 Q4 | 14.23 Billion USD | 37.37% |
| 2011 FY | 9.13 Billion USD | 55.25% |
| 2011 Q2 | 7.16 Billion USD | 2.62% |
| 2011 Q3 | 7.8 Billion USD | 8.96% |
| 2011 Q4 | 9.13 Billion USD | 17.05% |
| 2011 Q1 | 6.97 Billion USD | 18.62% |
| 2010 Q1 | 660.73 Million USD | -7.29% |
| 2010 FY | 5.88 Billion USD | 725.63% |
| 2010 Q3 | 5.78 Billion USD | 764.86% |
| 2010 Q4 | 5.88 Billion USD | 1.69% |
| 2010 Q2 | 669.04 Million USD | 1.26% |
| 2009 Q3 | 731.05 Million USD | -9.1% |
| 2009 Q2 | 804.23 Million USD | 111.59% |
| 2009 Q4 | 712.67 Million USD | -2.51% |
| 2009 FY | 712.67 Million USD | 68.89% |
| 2009 Q1 | 380.09 Million USD | -9.92% |
| 2008 FY | 421.96 Million USD | -12.87% |
| 2008 Q4 | 421.96 Million USD | 25.18% |
| 2008 Q3 | 337.07 Million USD | -26.15% |
| 2008 Q1 | 499.11 Million USD | 3.06% |
| 2008 Q2 | 456.45 Million USD | -8.55% |
| 2007 Q2 | 380.31 Million USD | -55.34% |
| 2007 FY | 484.29 Million USD | -45.59% |
| 2007 Q3 | 332.46 Million USD | -12.58% |
| 2007 Q1 | 851.5 Million USD | -4.34% |
| 2007 Q4 | 484.29 Million USD | 45.67% |
| 2006 Q2 | 760.52 Million USD | -2.82% |
| 2006 FY | 890.14 Million USD | 10.09% |
| 2006 Q1 | 782.57 Million USD | -3.21% |
| 2006 Q3 | 802.96 Million USD | 5.58% |
| 2006 Q4 | 890.14 Million USD | 10.86% |
| 2005 Q3 | 731.7 Million USD | -3.06% |
| 2005 Q1 | 645.37 Million USD | -1.3% |
| 2005 Q2 | 754.79 Million USD | 16.95% |
| 2005 Q4 | 808.54 Million USD | 10.5% |
| 2005 FY | 808.54 Million USD | 23.66% |
| 2004 Q4 | 653.86 Million USD | -15.55% |
| 2004 Q2 | 830.03 Million USD | -9.46% |
| 2004 Q1 | 916.78 Million USD | -11.95% |
| 2004 Q3 | 774.3 Million USD | -6.71% |
| 2004 FY | 653.86 Million USD | -37.2% |
| 2003 Q4 | 1.04 Billion USD | -1.64% |
| 2003 Q3 | 1.05 Billion USD | -2.58% |
| 2003 Q2 | 1.08 Billion USD | 26.83% |
| 2003 Q1 | 856.74 Million USD | -13.3% |
| 2003 FY | 1.04 Billion USD | 5.37% |
| 2002 Q4 | 988.11 Million USD | 35.02% |
| 2002 Q1 | 616.6 Million USD | 200.18% |
| 2002 Q3 | 731.81 Million USD | -2.18% |
| 2002 Q2 | 748.1 Million USD | 21.33% |
| 2002 FY | 988.11 Million USD | 381.05% |
| 2001 Q4 | 205.4 Million USD | -64.96% |
| 2001 FY | 205.4 Million USD | -76.38% |
| 2001 Q1 | 751.75 Million USD | -13.57% |
| 2001 Q2 | 721.41 Million USD | -4.04% |
| 2001 Q3 | 586.28 Million USD | -18.73% |
| 2000 Q2 | 368.38 Million USD | 0.25% |
| 2000 FY | 869.8 Million USD | 335.34% |
| 2000 Q1 | 367.48 Million USD | 83.93% |
| 2000 Q4 | 869.8 Million USD | 134.14% |
| 2000 Q3 | 371.49 Million USD | 0.84% |
| 1999 Q2 | 156.9 Million USD | 0.19% |
| 1999 Q3 | 170.9 Million USD | 8.92% |
| 1999 Q4 | 199.8 Million USD | 16.91% |
| 1999 FY | 199.8 Million USD | 34.36% |
| 1999 Q1 | 156.6 Million USD | 5.31% |
| 1998 Q1 | 37.6 Million USD | 106.59% |
| 1998 Q3 | 33.8 Million USD | 13.42% |
| 1998 Q2 | 29.8 Million USD | -20.74% |
| 1998 FY | 148.7 Million USD | 717.03% |
| 1998 Q4 | 148.7 Million USD | 339.94% |
| 1997 Q1 | 18.8 Million USD | -13.36% |
| 1997 Q4 | 18.2 Million USD | -13.33% |
| 1997 Q3 | 21 Million USD | 28.83% |
| 1997 Q2 | 16.3 Million USD | -13.3% |
| 1997 FY | 18.2 Million USD | -16.13% |
| 1996 Q2 | 42.6 Million USD | -13.41% |
| 1996 Q3 | 35.7 Million USD | -16.2% |
| 1996 Q4 | 21.7 Million USD | -39.22% |
| 1996 Q1 | 49.2 Million USD | 6.26% |
| 1996 FY | 21.7 Million USD | -53.13% |
| 1995 Q4 | 46.3 Million USD | 0.42% |
| 1995 FY | 46.3 Million USD | 158.66% |
| 1995 Q3 | 46.1 Million USD | -0.25% |
| 1995 Q1 | 15.9 Million USD | -11.17% |
| 1995 Q2 | 46.21 Million USD | 190.69% |
| 1994 Q4 | 17.9 Million USD | 0.0% |
| 1994 FY | 17.9 Million USD | -30.89% |
| 1993 FY | 25.9 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 3.45 Billion USD | -694.541% |
| Catalent, Inc. | 6.14 Billion USD | -346.121% |
| Emergent BioSolutions Inc. | 1.18 Billion USD | -2213.765% |
| Elanco Animal Health Incorporated | 8.13 Billion USD | -237.044% |
| Perrigo Company plc | 6.04 Billion USD | -354.082% |
| Teva Pharmaceutical Industries Limited | 35.35 Billion USD | 22.405% |
| Zoetis Inc. | 9.29 Billion USD | -195.126% |